D.E. Wilcox

496 total citations
10 papers, 286 citations indexed

About

D.E. Wilcox is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D.E. Wilcox has authored 10 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D.E. Wilcox's work include Muscle Physiology and Disorders (5 papers), Genetic Neurodegenerative Diseases (5 papers) and RNA modifications and cancer (2 papers). D.E. Wilcox is often cited by papers focused on Muscle Physiology and Disorders (5 papers), Genetic Neurodegenerative Diseases (5 papers) and RNA modifications and cancer (2 papers). D.E. Wilcox collaborates with scholars based in United Kingdom, Hungary and Netherlands. D.E. Wilcox's co-authors include Richard H. Wilson, Tetsuo Ashizawa, Patricia Cuenca, Grant Hogg, M.A. Ferguson‐Smith, Jillian M. Couto, Gerardo Del Valle, Fernando Morales, Catherine F. Higham and Berit Adam and has published in prestigious journals such as Human Molecular Genetics, Heart and Journal of Medical Genetics.

In The Last Decade

D.E. Wilcox

10 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.E. Wilcox United Kingdom 8 250 165 60 48 30 10 286
Zuzana Mušová Czechia 8 221 0.9× 166 1.0× 61 1.0× 28 0.6× 35 1.2× 21 261
T Maríková Czechia 8 252 1.0× 173 1.0× 49 0.8× 24 0.5× 34 1.1× 16 294
E. Bonifazi Italy 12 366 1.5× 348 2.1× 149 2.5× 52 1.1× 30 1.0× 18 472
Michiel R. Fokkens Netherlands 9 206 0.8× 176 1.1× 64 1.1× 30 0.6× 25 0.8× 11 312
Aline Huguet France 8 324 1.3× 302 1.8× 66 1.1× 37 0.8× 23 0.8× 11 362
Kerri M. Carlson United States 6 269 1.1× 218 1.3× 34 0.6× 53 1.1× 51 1.7× 6 341
Nicolas Chrestian Canada 10 195 0.8× 142 0.9× 43 0.7× 62 1.3× 26 0.9× 24 272
Emilia K. Bijlsma Netherlands 10 273 1.1× 295 1.8× 141 2.4× 18 0.4× 47 1.6× 15 395
Manlio Giacanelli Italy 10 297 1.2× 288 1.7× 142 2.4× 36 0.8× 29 1.0× 14 403
Virginie François France 8 236 0.9× 110 0.7× 23 0.4× 56 1.2× 54 1.8× 8 310

Countries citing papers authored by D.E. Wilcox

Since Specialization
Citations

This map shows the geographic impact of D.E. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.E. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.E. Wilcox more than expected).

Fields of papers citing papers by D.E. Wilcox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.E. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.E. Wilcox. The network helps show where D.E. Wilcox may publish in the future.

Co-authorship network of co-authors of D.E. Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of D.E. Wilcox. A scholar is included among the top collaborators of D.E. Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.E. Wilcox. D.E. Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hilton‐Jones, David, Cheryl Longman, Richard Petty, et al.. (2012). Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1 – The patients’ perspective. Neuromuscular Disorders. 22(7). 597–603. 25 indexed citations
2.
McGowan, Ruth, Sarah J. Ross, Susan Holloway, et al.. (2012). Results of Duchenne muscular dystrophy family screening in practice: leaks rather than cascades?. Clinical Genetics. 83(2). 187–190. 6 indexed citations
3.
Morales, Fernando, Jillian M. Couto, Catherine F. Higham, et al.. (2012). Somatic instability of the expanded CTG triplet repeat in myotonic dystrophy type 1 is a heritable quantitative trait and modifier of disease severity. Human Molecular Genetics. 21(16). 3558–3567. 128 indexed citations
4.
Holloway, S, D.E. Wilcox, Allen J. Wilcox, et al.. (2007). Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland. Heart. 94(5). 633–636. 33 indexed citations
5.
Engelen, Baziel G.M. van, B. Eymard, & D.E. Wilcox. (2005). 123rd ENMC International Workshop: Management and Therapy in Myotonic Dystrophy, 6–8 February 2004, Naarden, The Netherlands. Neuromuscular Disorders. 15(5). 389–394. 15 indexed citations
6.
Lecky, Bryan, J. M. MacKenzie, Andrew Read, & D.E. Wilcox. (1991). X-linked and FSH dystrophies in one family. Neuromuscular Disorders. 1(4). 275–278. 8 indexed citations
7.
Cooke, Alexander, W. George Lanyon, D.E. Wilcox, et al.. (1990). Analysis of Scottish Duchenne and Becker muscular dystrophy families with dystrophin cDNA probes.. Journal of Medical Genetics. 27(5). 292–297. 12 indexed citations
8.
Tolmie, John, et al.. (1988). Palmoplantar keratoderma, nail dystrophy, and hereditary motor and sensory neuropathy: an autosomal dominant trait.. Journal of Medical Genetics. 25(11). 754–757. 5 indexed citations
9.
Wilcox, D.E., Alexander Cooke, E. Boyd, et al.. (1986). Duchenne muscular dystrophy due to familial Xp21 deletion detectable by DNA analysis and flow cytometry. Human Genetics. 73(2). 175–180. 34 indexed citations
10.
Wilcox, D.E., Nabeel A. Affara, James R. Yates, M.A. Ferguson‐Smith, & P. Pearson. (1985). Multipoint linkage analysis of the short arm of the human X chromosome in families with X-linked muscular dystrophy. Human Genetics. 70(4). 365–375. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuzana Mušová Breakdown of academic impact, for papers by T Maríková Breakdown of academic impact, for papers by E. Bonifazi Breakdown of academic impact, for papers by Michiel R. Fokkens Breakdown of academic impact, for papers by Aline Huguet Breakdown of academic impact, for papers by Kerri M. Carlson Breakdown of academic impact, for papers by Nicolas Chrestian Breakdown of academic impact, for papers by Emilia K. Bijlsma Breakdown of academic impact, for papers by Manlio Giacanelli Breakdown of academic impact, for papers by Virginie François
Rankless by CCL
2026